The new technique provides pairs of genetically matched cells to study disease

Researchers led by Dr Knut Woltjen reported a new gene editing method that can modify a single DNA base in the human genome with...
heart attacks

New Lab test to spot heart attacks faster and detect future risk

A new method has come up to diagnose heart attacks faster in patients already in the emergency department, which is also more accurate than...
brain activity tumor removal

Brain activity now measurable, claim scientists

A team of scientists and clinicians from the University of Cambridge, Addenbrooke's Hospital and Neurophys have come together to design a new way for...

Traces of caffeine in the blood can be indicative of Parkinson’s disease

Researchers at Juntendo University finds the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson’s disease. The finding is...
Image Courtesy: Economic Times

Reactions to the Union Budget, 2019 February 2019

  Rahul Paith, CEO, DocOnline.com This union budget has further showcased the government’s intent to provide an equal opportunity to small and medium...

New diagnostic test for Parkinson’s and dementia with Lewy bodies

Novel test for diagnosis of prion diseases offers the possibility of improving early diagnosis of Parkinson's disease and dementia with Lewy bodies. The group,...

Smartphone integrated artificial pancreas to alleviate diabetes

Smartphones are widely and vastly used by the scientists in the medical field nowadays as it carries out a lot of functions easily and...
asthma blood cancer

Asthma drug’s success determined by a protein

A novel study, succeeded in identifying patients with a form of severe asthma by measuring periostin concentrations in their airways. It can range from very...
longetivity

Longetivity vitamins prolong healthy aging

There are previously unrecognized roles of vitamins and minerals, that worked in promoting longetivity and fended off chronic diseases. A new study suggests that...
Multiple Sclerosis

‘Once-daily’ tablet for Multiple Sclerosis launched in India

Aubagio (Teriflunomide, 14 mg) a ‘once-daily’ tablet for Multiple Sclerosis (MS) was launched by Sanofi Genzyme in India. With symptoms like fatigue, poor vision, weakness...